Synthical
Your space
Profile
Favorites
Folders
Feeds
All articles
Oncology | Synthical
Articles about
Oncology
Tissue and Peripheral T-cell Repertoire Predicts Immunotherapy Response and Progression-Free Survival in NSCLC Patients.
20 November 2025 by
M. Pino-Gonzalez
and
others
Oncology
Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events
18 November 2025 by
M. J. M. Van Eijs
and
others
at
UMC Utrecht
Oncology
Large-scale multi-omic analysis identifies noncoding somatic driver mutations and nominates ZFP36L2 as a driver gene for pancreatic ductal adenocarcinoma
8 October 2025 by
Jilong Zhong
and
others
Oncology
Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence
2 October 2025 by
A. Ku
and
others
at
National Cancer Institute
Oncology
Deep learning NTCP model for late dysphagia after radiotherapy for head and neck cancer patients based on 3D dose, CT and segmentations
29 September 2025 by
S. P. De Vette
and
others
at
University of Texas MD Anderson Cancer Center
Oncology
Incorporating continuous mammographic density into the BOADICEA breast cancer risk prediction model
26 September 2025 by
L. Ficorella
and
others
Oncology
Multimodal AI-Based Risk Stratification for Distant Metastasis in Nasopharyngeal Carcinoma
24 September 2025 by
Jie Zhou
and
others
at
University of Warwick
Oncology
The Burden of Cancer and Pre-cancerous Conditions Among Transgender Individuals in a Large Healthcare Network
8 September 2025 by
Shujian Yang
and
others
at
University of Florida
Oncology
Associations of adherence to the World Cancer Research Fund lifestyle recommendations with health-related quality of life and fatigue in Adolescent and Young Adult (AYA) cancer survivors: results from the SURVAYA study
8 September 2025 by
M. -F. Kenkhuis
and
others
Oncology
Mathematical model suggests current CAR-macrophage dosage is efficient to low pre-infusion tumour burden but refractory to high tumour burden
5 September 2025 by
Shuolin Xu
and
Mutian Liu
at
Israel Institute of Technology
Oncology
Interpreting convolutional neural network explainability for head-and-neck cancer radiotherapy organ-at-risk segmentation
20 August 2025 by
V. I. J. Strijbis
and
others
Oncology
Translation and Validation of the Brazilian: Portuguese version of Quality of Life on Vascular Access Devices Specific Questionnaire in Chemotherapy patients
29 July 2025 by
B. Jeronimo Ponte
and
others
Oncology
Ex Vivo Drug Responses and Molecular Profiles of 597 Pediatric Acute Lymphoblastic Leukemia Patients
28 July 2025 by
A. Enblad
and
others
Oncology
A 20-feature radiomic signature of triple-negative breast cancer identifies patients at high risk of death
26 July 2025 by
Humaira Noor
and
others
at
Stanford University
Oncology
Cell-based assay for blood-based diagnostics enhances prediction of lung cancer in patients with lung nodules
26 July 2025 by
J. Berndt
and
others
at
Institute for Systems Biology
Oncology
Survival-Inferred Fragility of Statistical Significance in Phase III Oncology Trials
24 July 2025 by
A. Sherry
and
others
Oncology
Inconsistency Detection In Cancer Data Classification Using Explainable-AI
21 July 2025 by
Pouria Mortezaagha
and
Arya Rahgozar
Oncology
Napsin A-specific T cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer
21 July 2025 by
N. Miller
and
others
Oncology
Adapting the BOADICEA breast and ovarian cancer risk models for the ethnically diverse UK population
17 July 2025 by
L. Ficorella
and
others
Oncology
Data-centric Artificial Intelligence and Cancer Research: Construction of a Real-World Head and Neck Treatment Data Repository
17 July 2025 by
V. Butterworth
and
others
Oncology
Integrating anamnestic and lifestyle data with sphingolipids levels for risk-based prostate cancer screening
14 July 2025 by
C. Peraldo-Neia
and
others
Oncology
Technical Development and In Silico Implementation of SyntheticMR in Head and Neck Adaptive Radiation Therapy: A Prospective R-IDEAL Stage 0/1 Technology Development Report
11 July 2025 by
Lucas Mccullum
and
others
at
University of Texas MD Anderson Cancer Center
Oncology
Health Utility Adjusted Survival: a Composite Endpoint for Clinical Trial Designs
9 July 2025 by
Yinlin Deng
and
others
Oncology
Identification of colorectal malignancies enabled by phasor-based autofluorescence lifetime macroimaging and ensemble learning
5 July 2025 by
J. Lagarto
and
others
Oncology
EsoDetect: Computational Validation and Algorithm Development of a Novel Diagnostic and Prognostic Tool for Dysplasia in Barrett's Esophagus
3 July 2025 by
M. Miskinyte
and
others
Oncology
Adjuvant pembrolizumab after upfront multimodal therapy for stage IVB Anaplastic Thyroid Cancer
3 July 2025 by
M. Cabanillas
and
others
Oncology
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients
2 July 2025 by
T. Severson
and
others
Oncology
LncRNA antigens- a novel resource to improve immunotherapy efficacy predictions in Melanoma
30 June 2025 by
Shez Malik
and
Allison Golden
Oncology
Comprehensive profiling of the mutational landscape of hidradenoma papilliferum validates key role of alterations in the PI3K/AKT pathway alterations
28 June 2025 by
Salar Cheema
and
others
at
Wellcome Sanger Institute
Oncology
Effects of chemotherapy on skeletal muscle mitochondrial oxidative capacity using Near-Infrared Spectroscopy (NIRS): Protocol paper for an observational mixed model repeated measures design in patients with breast and gynecological cancer
27 June 2025 by
R. Hutchison
and
others
at
Furman University
Oncology
Load more